"Kaléo is a pharmaceutical company dedicated to building innovative solutions that can help empower patients with certain serious and life-threatening medical conditions. An industry leader in human factors engineering, we believe patients and caregivers are the experts on how medical conditions impact their lives, and so we include them as an integral part of our innovative development process. Headquartered in Richmond, VA, Kaléo is a privately-held company."

During the past decade, Altana/Nycomed conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Altana/Nycomed" are "Hay Fever" (4 trials), "Rhinitis, Allergic, Perennial" (3 trials), "Allergic Rhinitis" (2 trials), "Perennial Allergic Rhinitis" (2 trials) and "Rhinitis, Allergic, Seasonal" (2 trials). Many other conditions were trialed in "Altana/Nycomed" in a lesser frequency.

Most popular intervention types in "Altana/Nycomed" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Ciclesonide" (5 trials), "Placebo" (4 trials), "Ciclesonide HFA" (1 trials), "Ciclesonide nasal spray" (1 trials) and "Ciclesonide nasal spray + Azelastine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Altana/Nycomed" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Altana/Nycomed". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Altana/Nycomed, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Altana/Nycomed, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".